California Public Employees Retirement System
INZY

California Public Employees Retirement System’s Inozyme Pharma INZY Stock Holding History

California Public Employees Retirement System’s Portfolio INZY Stock Details INZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-14,400
Closed -$285K – 2221
2021
Q1 		$285K Sell
14,400
-1,311
-8% -$28.9K ﹤0.01% 3245
2020
Q4 		$324K Sell
15,711
-300
-2% -$7.15K ﹤0.01% 3163
2020
Q3 		$421K Buy
+16,011
New +$398K ﹤0.01% 2873

Other funds holding INZY

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

California Public Employees Retirement System's INZY Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Inozyme Pharma (INZY) in Q2 2021, closing a stake of 14,400 shares — an estimated $285K sold.

California Public Employees Retirement System first reported a position in INZY in Q3 2020 and held it in 3 quarters. The position peaked at $421K in Q3 2020. 50 funds tracked by Wall St. Rank hold INZY as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Inozyme Pharma position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 14,400 Inozyme Pharma shares in Q2 2021, an estimated $285K.
  • California Public Employees Retirement System first reported a position in Inozyme Pharma in Q3 2020 and held it in 3 quarters.
  • California Public Employees Retirement System's Inozyme Pharma position peaked at $421K in Q3 2020.
  • 50 funds tracked by Wall St. Rank held Inozyme Pharma as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.